Advertisement

Reproductive Sciences

, Volume 19, Issue 4, pp 360–373 | Cite as

Valproic Acid and Progestin Inhibit Lesion Growth and Reduce Hyperalgesia in Experimentally Induced Endometriosis in Rats

  • Maohua Liu
  • Xishi Liu
  • Yuqiu Zhang
  • Sun-Wei GuoEmail author
Article

Abstract

Accumulating evidence suggests that endometriosis is an epigenetic disease. This study was designed to evaluate the effect of valproic acid (VPA) and progesterone (P4) in a rat model of endometriosis on serum tumor necrosis factor-α (TNF-α) levels, hot plate and tail-flick latencies, lesion size, and body weight. We used 77 adult female rats, and endometriosis was induced by autotransplanting pieces of uterus (ENDO) or fat (SHAM) to the pelvic cavity. The BLANK group received no surgery. After 2 weeks, the ENDO group was further divided, randomly, into 5 groups, receiving, respectively, treatment with low- and high-dose VPA, P4 alone, VPA + P4, and no treatment. The SHAM rats received no treatment. The BLANK rats were further divided into 2 groups, one received VPA treatment and the other, no treatment. After 4 weeks, all rats were sacrificed. Response latency in hot plate and tail-flick tests, body weight, and serum TNF-α levels were measured before the surgery, before and after the treatment, along with lesion size. We found that induced endometriosis reduced response latency. ENDO rats receiving VPA and/or P4 treatment had significantly reduced lesion size as compared with untreated ones, and had significantly improved response to noxious thermal stimuli. They also had significantly increased weight gain. Serum TNF-α levels increased following surgery but eventually decreased regardless of treatment or not. In conclusion, VPA is well tolerated. Treatment with VPA significantly reduces lesion growth and improves sensitivity to nocifensive stimuli. The improvement is specific to endometriosis-induced hyperalgesia. Thus, histone deacetylase inhibitors may be a promising therapeutics for treating endometriosis.

Keywords

endometriosis histone deacetylase inhibitor hot plate test tail-flick test hyperalgesia inflammation progestin 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Giudice LC, Kao LC. Endometriosis. Lancet. 2004;364(9447):1789–1799.Google Scholar
  2. 2.
    Olive DL, Lindheim SR, Pritts EA. New medical treatments for endometriosis. Best Pract Res Clin Obstet Gynaecol. 2004;18(2):319–328.PubMedCrossRefPubMedCentralGoogle Scholar
  3. 3.
    Olive DL, Pritts EA. Treatment of endometriosis. N Engl J Med.2001;345(4):266–275.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Nothnick WB, D’Hooghe TM. Medical management of endometriosis: novel targets and approaches towards the development of future treatment regimes. Gynecol Obstet Invest. 2003;55(4):189–198.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Wu Y, Halverson G, Basir Z, Strawn E, Yan P, Guo SW. Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol. 2005;193(2):371–380.PubMedCrossRefPubMedCentralGoogle Scholar
  6. 6.
    Wu Y, Starzinski-Powitz A, Guo SW. Prolonged stimulation with tumor necrosis factor-alpha induced partial methylation at PR-B promoter in immortalized epithelial-like endometriotic cells. Fertil Steril. 2008;90(1):234–237.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril. 2007;87(1):24–32.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Ailawadi RK, Jobanputra S, Kataria M, Gurates B, Bulun SE. Treatment of endometriosis and chronic pelvic pain with letrozole and norethindrone acetate: a pilot study. Fertil Steril. 2004;81(2):290–296.PubMedCrossRefPubMedCentralGoogle Scholar
  9. 9.
    Xue Q, Lin Z, Cheng YH, Huang CC, et al. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod. 2007;77(4):681–687.PubMedCrossRefGoogle Scholar
  10. 10.
    Xue Q, Lin Z, Yin P, et al. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5′ CpG island in endometriosis. J Clin Endocrinol Metab. 2007;92(8):3261–3267.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Kim JJ, Taylor HS, Lu Z, et al. Altered expression of HOXA10 in endometriosis: potential role in decidualization. Mol Hum Reprod. 2007;13(5):323–332.PubMedCrossRefPubMedCentralGoogle Scholar
  12. 12.
    Lee B, Du H, Taylor HS. Experimental murine endometriosis induces DNA methylation and altered gene expression in eutopic endometrium. Biol Reprod. 2009;80(1):79–85.PubMedPubMedCentralCrossRefGoogle Scholar
  13. 13.
    Szczepanska M, Wirstlein P, Luczak M, Jagodzinski PP, Skrzypczak J. Reduced expression of HOXA10 in the midluteal endometrium from infertile women with minimal endometriosis. Biomed Pharmacother. 2010;64(10):697–705.PubMedCrossRefPubMedCentralGoogle Scholar
  14. 14.
    Izawa M, Taniguchi F, Uegaki T, et al. Demethylation of a non-promoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues. Fertil Steril. 2010;95(1):33–39.PubMedCrossRefPubMedCentralGoogle Scholar
  15. 15.
    Borghese B, Barbaux S, Mondon F, et al. Research resource: genome-wide profiling of methylated promoters in endometriosis reveals a subtelomeric location of hypermethylation. Mol Endocrinol. 2010;24(9):1872–1885.PubMedPubMedCentralCrossRefGoogle Scholar
  16. 16.
    Guo SW. Epigenetics of endometriosis. Mol Hum Reprod. 2009;15(10):587–607.PubMedCrossRefPubMedCentralGoogle Scholar
  17. 17.
    Guo SW. Emerging drugs for endometriosis. Expert Opin Emerg Drugs. 2008;13(4):547–571.PubMedCrossRefPubMedCentralGoogle Scholar
  18. 18.
    Nie J, Liu XS, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in Adenomyosis and its rectification by a histone deacetylase inhibitor and a demethylation agent. Reprod Sci. 2010;17(11):995–1005.CrossRefGoogle Scholar
  19. 19.
    Wu Y, Guo SW. Inhibition of proliferation of endometrial stromal cells by trichostatin A, RU486, CDB-2914, N-acetylcysteine, and ICI 182780. Gynecol Obstet Invest. 2006, 62(4):193–205.PubMedCrossRefPubMedCentralGoogle Scholar
  20. 20.
    Wu Y, Guo SW. Histone deacetylase inhibitors trichostatin A and valproic acid induce cell cycle arrest and p21 expression in immortalized human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol. 2008, 137(2):198–203.CrossRefGoogle Scholar
  21. 21.
    Wu Y, Starzinski-Powitz A, Guo SW. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. Reprod Sci. 2007;14(4):374–382.PubMedCrossRefPubMedCentralGoogle Scholar
  22. 22.
    Wu Y, Starzinski-Powitz A, Guo SW. Constitutive and tumor necrosis factor-alpha-stimulated activation of nuclear factor-kappaB in immortalized endometriotic cells and their suppression by trichostatin A. Gynecol Obstet Invest. 2010;70(1):23–33.PubMedCrossRefPubMedCentralGoogle Scholar
  23. 23.
    Lu Y, Nie J, Liu X, Zheng Y, Guo SW. Trichostatin A, a histone deacetylase inhibitor, reduces lesion growth and hyperalgesia in experimentally induced endometriosis in mice. Hum Reprod. 2010;25(4):1014–1025.PubMedCrossRefGoogle Scholar
  24. 24.
    Richter ON, Dorn C, Rosing B, Flaskamp C, Ulrich U. Tumor necrosis factor alpha secretion by peritoneal macrophages in patients with endometriosis. Arch Gynecol Obstet. 2005;271(2):143–147.PubMedCrossRefPubMedCentralGoogle Scholar
  25. 25.
    Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol. 1992;107(3):660–664.PubMedPubMedCentralCrossRefGoogle Scholar
  26. 26.
    Fang Z, Yang S, Gurates B, et al. Genetic or enzymatic disruption of aromatase inhibits the growth of ectopic uterine tissue. J Clin Endocrinol Metab. 2002;87(7):3460–3466.PubMedPubMedCentralCrossRefGoogle Scholar
  27. 27.
    Berkley KJ, Cason A, Jacobs H, Bradshaw H, Wood E. Vaginal hyperalgesia in a rat model of endometriosis. Neurosci Lett. 2001;306(3):185–188.PubMedCrossRefPubMedCentralGoogle Scholar
  28. 28.
    Le Bars D, Gozariu M, Cadden SW. Animal models of nociception. Pharmacol Rev. 2001;53(4):597–652.PubMedPubMedCentralGoogle Scholar
  29. 29.
    Bannon AW, Malmberg AB. Models of nociception: hot-plate, tail-flick, and formalin tests in rodents. Curr Protoc Neurosci. 2007;Chapter 8: Unit 8 9.Google Scholar
  30. 30.
    Inhaka R, Gentleman RR. R: a language for data analysis and graphics. J comput Graph Statist. 1996;5(3):1923–1927.Google Scholar
  31. 31.
    He W, Liu XS, Zhang YQ, Guo SW. Generalized hyperalgesia in women with endometriosis and its resolution following a successful surgery. Reprod Sci. 2010;17(12):1099–1111.PubMedCrossRefPubMedCentralGoogle Scholar
  32. 32.
    Berkley KJ, McAllister SL, Accius BE, Winnard KP. Endometriosis-induced vaginal hyperalgesia in the rat: effect of estropause, ovariectomy, and estradiol replacement. Pain. 2007;132(suppl 1):S150–S159.PubMedPubMedCentralCrossRefGoogle Scholar
  33. 33.
    Zhao T, Liu X, Zhen X, Guo SW. Levo-Tetrahydropalmatine (l-THP) retards the growth of ectopic endometrial implants and alleviates generalized hyperalgesia in experimentally induced endometriosis in rats. Reprod Sci. 2010;18(1):28–45.PubMedCrossRefPubMedCentralGoogle Scholar
  34. 34.
    Vierck CJ Animal models of pain. In: McMahon S, Koltzenburg M, (eds.) Wall and Melzack’s Textbook of Pain. 5th ed. Philadelphia, PA: Elsevier, 2006, 175–185.CrossRefGoogle Scholar
  35. 35.
    Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol. 2003;49(5):285–296.PubMedCrossRefPubMedCentralGoogle Scholar
  36. 36.
    Ji RR, Kohno T, Moore KA, Woolf CJ. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci. 2003;26(12):696–705.PubMedCrossRefPubMedCentralGoogle Scholar
  37. 37.
    McAllister SL, McGinty KA, Resuehr D, Berkley KJ. Endometriosis-induced vaginal hyperalgesia in the rat: role of the ectopic growths and their innervation. Pain. 2009;147(1–3):255–264.PubMedPubMedCentralCrossRefGoogle Scholar
  38. 38.
    Latremoliere A, Woolf CJ. Central sensitization: a generator of pain hypersensitivity by central neural plasticity. J Pain. 2009;10(9):895–926.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Matsuzaki S, Canis M, Pouly JL, Rabischong B, Botchorishvili R, Mage G. Relationship between delay of surgical diagnosis and severity of disease in patients with symptomatic deep infiltrating endome-triosis. Fertil Steril. 2006;86(5):1314–1316; discussion 1317.PubMedCrossRefPubMedCentralGoogle Scholar
  40. 40.
    Harada T, Iwabe T, Terakawa N. Role of cytokines in endometriosis. Fertil Steril. 2001;76(1):1–10.PubMedCrossRefPubMedCentralGoogle Scholar
  41. 41.
    Shirley SW, Stewart BH, Mirelman S. Dimethyl sulfoxide in treatment of inflammatory genitourinary disorders. Urology. 1978;11(3):215–220.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Swanson BN. Medical use of dimethyl sulfoxide (DMSO). Rev Clin Basic Pharm. 1985;5(1–2):1–33.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Bedaiwy MA, Falcone T, Sharma RK, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod. 2002;17(2):426–431.PubMedCrossRefPubMedCentralGoogle Scholar
  44. 44.
    May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update. 2010;16(6):651–674.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Malick A, Jakubowski M, Elmquist JK, Saper CB, Burstein R. A neurohistochemical blueprint for pain-induced loss of appetite. Proc Natl Acad Sci U S A. 2001;98(17):9930–9935.PubMedPubMedCentralCrossRefGoogle Scholar
  46. 46.
    Stevenson GW, Bilsky EJ, Negus SS. Targeting pain-suppressed behaviors in preclinical assays of pain and analgesia: effects of morphine on acetic acid-suppressed feeding in C57BL/6 J mice. J Pain. 2006;7(6):408–416.PubMedCrossRefPubMedCentralGoogle Scholar
  47. 47.
    Spannhoff A, Kim YK, Raynal NJ, et al. Histone deacetylase inhibitor activity in royal jelly might facilitate caste switching in bees. EMBO Rep. 2011;12(3):238–243.PubMedPubMedCentralCrossRefGoogle Scholar
  48. 48.
    Kucharski R, Maleszka J, Foret S, Maleszka R. Nutritional control of reproductive status in honeybees via DNA methylation. Science. 2008;319(5871):1827–1830.PubMedCrossRefPubMedCentralGoogle Scholar
  49. 49.
    Kim HJ, Bae SC. Histone deacetylase inhibitors: molecular mechanisms of action and clinical trials as anti-cancer drugs. Am J Transl Res. 2011;3(2):166–179.PubMedPubMedCentralGoogle Scholar
  50. 50.
    Giudice LC. Clinical practice. Endometriosis. N Engl J Med. 2010;362(25):2389–2398.PubMedPubMedCentralCrossRefGoogle Scholar
  51. 51.
    Vercellini P, Cortesi I, Crosignani PG. Progestins for symptomatic endometriosis: a critical analysis of the evidence. Fertil Steril. 1997;68(3):393–401.PubMedCrossRefPubMedCentralGoogle Scholar
  52. 52.
    Attia GR, Zeitoun K, Edwards D, Johns A, Carr BR, Bulun SE. Progesterone receptor isoform A but not B is expressed in endometriosis. J Clin Endocrinol Metab. 2000;85(8):2897–2902.PubMedPubMedCentralGoogle Scholar
  53. 53.
    Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics. 2006;1(2):106–111.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Wu Y, Guo SW. Suppression of IL-1beta-induced COX-2 expression by trichostatin A (TSA) in human endometrial stromal cells. Eur J Obstet Gynecol Reprod Biol. 2007;135(1): 88–93.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Tsai SJ, Wu MH, Lin CC, Sun HS, Chen HM. Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. J Clin Endocrinol Metab. 2001;86(12):5765–5773.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Attar E, Tokunaga H, Imir G, et al. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. J Clin Endocrinol Metab. 2009;94(2):623–631.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Xishi L, Lei Y, Guo SW. Valproic acid as a therapy for adenomyosis: a comparative case series. Reprod Sci. 2010;17(10):904–912.CrossRefGoogle Scholar

Copyright information

© Society for Reproductive Investigation 2012

Authors and Affiliations

  • Maohua Liu
    • 1
  • Xishi Liu
    • 1
  • Yuqiu Zhang
    • 2
  • Sun-Wei Guo
    • 1
    Email author
  1. 1.Shanghai Obstetrics and Gynecology HospitalFudan University Shanghai College of MedicineShanghaiChina
  2. 2.State Key Laboratory of Medical Neurobiology and Institute of Brain ScienceFudan UniversityShanghaiChina

Personalised recommendations